SHAHRZAD IRANI: Open Payments
NPI 1487348876 · TURLOCK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,488 in 54 payments from 9 companies in 2025. Trend: 2023 $29 · 2024 $1,566 · 2025 $2,488
Food & beverage: $1,608Travel & lodging: $880
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 14 | $1,128 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $642 |
| GENZYME CORPORATION | 2 | $275 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $164 |
| Madrigal Pharmaceuticals | 1 | $147 |
| ABBVIE INC. | 2 | $56 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Virtus Pharmaceuticals LLC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: PROCLAIM, XIFAXAN, RELISTOR, DUPIXENT, JOURNAVX, REZDIFFRA, XTAMPZA, UBRELVY.
Industry payments across CA — which companies pay providers there.
